Type I Protein Arginine Methyltransferases Overexpression Promotes Transformation and Potentiates Her2/Neu-Driven Tumorigenesis

Cancer Res. 2019 Jan 1;79(1):3-4. doi: 10.1158/0008-5472.CAN-18-3552.

Abstract

Bao and colleagues demonstrate that type I protein arginine methyltransferases (PRMT) are directly involved in mammary gland transformation and tumor progression. Notably, several distinct phenotypes require further investigation such as PRMT1/CARM1-induced transformation, CARM1-mediated delay in tumorigenesis, and PRMTs potentiation of Her2-dependent tumors. The PRMT overexpression transgenic mouse models should encourage and facilitate further mechanistic interrogation and the development of PRMT-directed therapies.See related article by Bao et al., p. 21.

Publication types

  • Comment

MeSH terms

  • Animals
  • Carcinogenesis
  • Mice
  • Mice, Transgenic
  • Neoplasms*
  • Oncogenes
  • Protein-Arginine N-Methyltransferases / genetics*

Substances

  • Protein-Arginine N-Methyltransferases